Abstract
Objective To compare the gradient distribution of estrogen and progesterone receptor in the whole layers of the uterus (mucous, superficial myometrium, deep myometrium layer and subserious layers) by the expression of estrogen and progesterone receptors. Methods To evaluate the distribution and intensity of estrogen receptor (ER) and progesterone receptor (PR) stained in the various part of human endometrium and myometrium, two different diseases were chosen in the menopause and adenomyosis group. Immuno-histochemical study was performed on ER and PR in the whole layers (mucous layer, superficial myometrium layer, and deep myometrium layer). Results There was significant difference in distribution of ER and PR between endometrium and other layers (P＜0.01) in menopause group. There was significant difference in distribution of ER and PR between subserous and other layers (P=0.000) in adenomyosis group. Conclusions In menopause ER and PR levels is maximum in the endometrium. So the endometrial abalation is effective for the tamoxifen-treated breast cancer patients.
Key words
estrogen receptor /
progesterone receptor /
tamoxifen /
adenomyosis
Cite this article
Download Citations
LI Jing,FENG Limin,and LIU Hui.
Level distribution of estrogen receptor and progesterone receptor in human uterus of menopause and adenomyosis group[J]. Medical Journal of the Chinese People Armed Police Forces. 2013, 24(1): 37-40
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
［1］ Cowley S M，Parker M G. Acomparison of transxriiptional activation by ER alpha and ER beta ［J］. Steroid Biochem Mol Biol，1999，69：165-175.
［2］ Cowley S M，Hoare S，Mosselman S，et al. Estrogen receptors alpha and beta form heterodimers on DNA ［J］. Biolchem，1997，272：19858-19862.
［3］ 屠 铮，李小平，魏丽惠. 孕激素受体亚型的研究现状 ［J］. 国外医学妇产科学分册， 2000，27(5)：259.
［4］ Matsuzaki S，Fukaya T，Uenara S， et al. Characterization of messenger RNA expression of estrogen receptor and in patients with ovarian endometriosis ［J］. Fertil Steril，2000，73(6)：1219.
［5］ Bergeron C，Amant F，Ferenczy A．Pathology and physiopathology of adenomyosis［J］.Clin Obstet Gynan，2006，20(4)：515-516．
［6］ Renner S P，Strick R，Oppelt P， et al．Evaluation of clinical parameters and estrogen receptor alpha gene for patients with endometriosis［J］．Reproduction，2006，131(1)：153.
［7］ 关 铮. 雌激素受体亚型与子宫内膜异位症相关性研究进展［J］.武警医学, 2008，19(4)：353-355.
［8］ 李静勉，张小丹.雌激素受体、孕激素受体与凋亡基因蛋白在子宫腺肌症中的表达 ［J］.中国实用医药，2009，26(4)：17-18.
［9］ 冯力民，魏丽惠，新一代子宫内膜去除术［J］.中国妇产科临床杂志，2004，5(4)：311-313.
［10］ 夏恩兰，段 华，刘玉环，等. 宫腔镜子宫内膜切除术的临床应用即远期疗效分析［J］.中华妇产科杂志，2004，39(5)：296-300.
［11］ 李晶华.ER、PR对妇科疾病影响研究进展［J］.国际妇产科学杂志，2008，35（1）：50-53.
［12］ 周 蓉，崔 恒，魏丽惠.ER、PR在绝经期子宫内膜息肉中的表达及其对治疗方式的启示［J］.北京医学，2006,28（9）：520-521.
［13］ Shushan A，Revel A，Laufer N，et al. Hysteroscopic treatment of intrauterine lesions in premenopausal and postmenopausal women［J］． Am Asso Gynecol Laparosc，2002，9：209-213．
PDF(1239 KB)
